148 related articles for article (PubMed ID: 35351403)
21. MiR-203 Interplays with Polycomb Repressive Complexes to Regulate the Proliferation of Neural Stem/Progenitor Cells.
Liu PP; Tang GB; Xu YJ; Zeng YQ; Zhang SF; Du HZ; Teng ZQ; Liu CM
Stem Cell Reports; 2017 Jul; 9(1):190-202. PubMed ID: 28602614
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2.
Zhang Y; Lin C; Liao G; Liu S; Ding J; Tang F; Wang Z; Liang X; Li B; Wei Y; Huang Q; Li X; Tang B
Oncotarget; 2015 Oct; 6(32):32586-601. PubMed ID: 26452129
[TBL] [Abstract][Full Text] [Related]
23. Mutations and deletions of PRC2 in prostate cancer.
Jain P; Di Croce L
Bioessays; 2016 May; 38(5):446-54. PubMed ID: 27000413
[TBL] [Abstract][Full Text] [Related]
24. Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma.
Asangani IA; Harms PW; Dodson L; Pandhi M; Kunju LP; Maher CA; Fullen DR; Johnson TM; Giordano TJ; Palanisamy N; Chinnaiyan AM
Oncotarget; 2012 Sep; 3(9):1011-25. PubMed ID: 22948084
[TBL] [Abstract][Full Text] [Related]
25. Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target.
Wen Y; Cai J; Hou Y; Huang Z; Wang Z
Oncotarget; 2017 Jun; 8(23):37974-37990. PubMed ID: 28415635
[TBL] [Abstract][Full Text] [Related]
26. EZH1/2 as targets for cancer therapy.
An R; Li YQ; Lin YL; Xu F; Li MM; Liu Z
Cancer Gene Ther; 2023 Feb; 30(2):221-235. PubMed ID: 36369341
[TBL] [Abstract][Full Text] [Related]
27. The polycomb proteins EZH1 and EZH2 co-regulate chromatin accessibility and nephron progenitor cell lifespan in mice.
Liu H; Hilliard S; Kelly E; Chen CH; Saifudeen Z; El-Dahr SS
J Biol Chem; 2020 Aug; 295(33):11542-11558. PubMed ID: 32554463
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-144 suppresses tumorigenesis and tumor progression of astrocytoma by targeting EZH2.
Lin L; Zheng Y; Tu Y; Wang Z; Liu H; Lu X; Xu L; Yuan J
Hum Pathol; 2015 Jul; 46(7):971-80. PubMed ID: 25907866
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta.
Cao P; Deng Z; Wan M; Huang W; Cramer SD; Xu J; Lei M; Sui G
Mol Cancer; 2010 May; 9():108. PubMed ID: 20478051
[TBL] [Abstract][Full Text] [Related]
31. Unlocking adult T-cell leukemia/lymphoma's epigenetic secrets: delving into the mechanism and impact of EZH1/2 inhibition.
Tavakoli Shirazi P; Bywater MJ
Immunol Cell Biol; 2024; 102(5):298-301. PubMed ID: 38606590
[TBL] [Abstract][Full Text] [Related]
32. microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer.
Chen DL; Zhang DS; Lu YX; Chen LZ; Zeng ZL; He MM; Wang FH; Li YH; Zhang HZ; Pelicano H; Zhang W; Xu RH
Oncotarget; 2015 May; 6(13):10868-79. PubMed ID: 25869101
[TBL] [Abstract][Full Text] [Related]
33. Investigating the epi-miRNome: identification of epi-miRNAs using transfection experiments.
Reale E; Taverna D; Cantini L; Martignetti L; Osella M; De Pittà C; Virga F; Orso F; Caselle M
Epigenomics; 2019 Nov; 11(14):1581-1599. PubMed ID: 31693439
[No Abstract] [Full Text] [Related]
34. MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2.
Luo C; Merz PR; Chen Y; Dickes E; Pscherer A; Schadendorf D; Eichmüller SB
Cancer Lett; 2013 Dec; 341(2):240-7. PubMed ID: 23962556
[TBL] [Abstract][Full Text] [Related]
35. Polycomb repressive complex's evolutionary conserved function: the role of EZH2 status and cellular background.
Gall Trošelj K; Novak Kujundzic R; Ugarkovic D
Clin Epigenetics; 2016; 8():55. PubMed ID: 27239242
[TBL] [Abstract][Full Text] [Related]
36. The competitive mechanism of EZH1 and EZH2 in promoting oral squamous cell carcinoma.
Chen J; Tang S; Zheng Q; Li J; Jiang H; Lu H; Liao G; Li K; Liang Y
Exp Cell Res; 2024 Mar; 436(1):113957. PubMed ID: 38309675
[TBL] [Abstract][Full Text] [Related]
37. Mitochondria-targeting nano therapy altering IDH2-mediated EZH2/EZH1 interaction as precise epigenetic regulation in glioblastoma.
Kaundal B; Karmakar S; Roy Choudhury S
Biomater Sci; 2022 Sep; 10(18):5301-5317. PubMed ID: 35917200
[TBL] [Abstract][Full Text] [Related]
38. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM
Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683
[TBL] [Abstract][Full Text] [Related]
39. Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor.
Honma D; Kanno O; Watanabe J; Kinoshita J; Hirasawa M; Nosaka E; Shiroishi M; Takizawa T; Yasumatsu I; Horiuchi T; Nakao A; Suzuki K; Yamasaki T; Nakajima K; Hayakawa M; Yamazaki T; Yadav AS; Adachi N
Cancer Sci; 2017 Oct; 108(10):2069-2078. PubMed ID: 28741798
[TBL] [Abstract][Full Text] [Related]
40. Gestational diabetes mellitus impairs fetal endothelial cell functions through a mechanism involving microRNA-101 and histone methyltransferase enhancer of zester homolog-2.
Floris I; Descamps B; Vardeu A; Mitić T; Posadino AM; Shantikumar S; Sala-Newby G; Capobianco G; Mangialardi G; Howard L; Dessole S; Urrutia R; Pintus G; Emanueli C
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):664-74. PubMed ID: 25614281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
